Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT03057795
What this trial is testing

Nivolumab & Brentuximab Vedotin Consolidation After Autologous SCT in Patients With High-Risk Classical Hodgkin Lymphoma

Who this might be right for
Classic Hodgkin LymphomaRecurrent Hodgkin LymphomaRefractory Hodgkin Lymphoma
City of Hope Medical Center 62
Post-approval studies (Phase 4)Study completedNCT05442554
What this trial is testing

Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell Lymphoma

Who this might be right for
T-Cell Lymphoma
Takeda 10
Not applicableStudy completedNCT01868451
What this trial is testing

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 118
Testing effectiveness (Phase 2)Study completedNCT01979536
What this trial is testing

Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-PositiveAnn Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell LymphomaAnn Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma+1 more
National Cancer Institute (NCI) 137
Not applicableStudy completedNCT04998331
What this trial is testing

A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, Cutaneous
Takeda 51
Early research (Phase 1)Study completedNCT01596218
What this trial is testing

Brentuximab Vedotin for Steroid Refractory GvHD

Who this might be right for
Graft vs. Host Disease
Massachusetts General Hospital 35
Testing effectiveness (Phase 2)Study completedNCT02227433
What this trial is testing

Brentuximab Vedotin in the Elderly Hodgkin Lymphoma Patients at First Relapse or With Primary Refractory Disease.

Who this might be right for
Hodgkin Lymphoma
Fondazione Italiana Linfomi - ETS 20
Not applicableStudy completedNCT04213209
What this trial is testing

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Who this might be right for
Peripheral T Cell LymphomaPediatric Hodgkin Lymphoma
Takeda 95
Large-scale testing (Phase 3)Active Not RecruitingNCT03907488
What this trial is testing

Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma

Who this might be right for
Ann Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Lymphocyte-Depleted Classic Hodgkin LymphomaAnn Arbor Stage III Mixed Cellularity Classic Hodgkin Lymphoma+7 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01026415
What this trial is testing

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

Who this might be right for
CarcinomasDisease, HodgkinLymphoma, Large-Cell, Anaplastic+2 more
Seagen Inc. 73
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Large-scale testing (Phase 3)Study completedNCT02684292
What this trial is testing

Study of Pembrolizumab (MK-3475) vs. Brentuximab Vedotin in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-204/KEYNOTE-204)

Who this might be right for
Hodgkin Lymphoma
Merck Sharp & Dohme LLC 304
Testing effectiveness (Phase 2)Study completedNCT02588651
What this trial is testing

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

Who this might be right for
T-cell LymphomaAngioimmunoblastic T-cell LymphomaHepato-splenic T-cell Lymphoma+3 more
Deepa Jagadeesh 23
Large-scale testing (Phase 3)Looking for participantsNCT05675410
What this trial is testing

Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

Who this might be right for
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
National Cancer Institute (NCI) 1,875
Testing effectiveness (Phase 2)Looking for participantsNCT05149768
What this trial is testing

Open Label Extension Study of Brentuximab Vedotin in Early dcSSc

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 11
Not applicableStudy completedNCT07145125
What this trial is testing

Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
University Hospital, Bordeaux 222
Testing effectiveness (Phase 2)Study completedNCT01534078
What this trial is testing

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Testing effectiveness (Phase 2)Study completedNCT02567851
What this trial is testing

Brentuximab Vedotin in Patients With Hodgkin Lymphoma Unsuitable for Chemotherapy Due to Age, Frailty or Co-morbidity

Who this might be right for
Hodgkin Disease
University of Birmingham 38
Post-approval studies (Phase 4)Not Yet RecruitingNCT06761911
What this trial is testing

BV in the Treatment of Relapsed/refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma (Category)
Xiuhua Sun 100
Next Page
994